<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00519506</url>
  </required_header>
  <id_info>
    <org_study_id>CAN/US-002-II-PE</org_study_id>
    <nct_id>NCT00519506</nct_id>
  </id_info>
  <brief_title>A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli</brief_title>
  <official_title>A Phase II Study to Evaluate the Efficacy of Anti-Fibrin Humanized Monoclonal Antibody(DI-DD3B6/22-80B3) Fab' Fragment (ThromboView®) Conjugated With Technetium-99m in the Detection of Pulmonary Emboli</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agen Biomedical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Agen Biomedical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine the diagnostic accuracy of 99mTc ThromboView® SPECT&#xD;
      imaging for the detection of acute pulmonary embolism (PE) in patients for whom there is a&#xD;
      moderate to high clinical suspicion for PE.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Provide estimates of the sensitivity of 99mTc ThromboView® in subjects with confirmed PE, as determined by computed tomographic pulmonary angiography (CTPA) and the specificity of 99mTc ThromboView® in subjects with PE excluded by CTPA</measure>
    <time_frame>June 2008</time_frame>
  </primary_outcome>
  <enrollment type="Actual">61</enrollment>
  <condition>Acute Pulmonary Embolism</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ThromboView</intervention_name>
    <description>Radiopharmaceutical, single dose, of the diagnosis of venous thromboembolism</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Written consent by the subject to participate in the study.&#xD;
&#xD;
          2. Moderate to high pre-test probability of acute pulmonary embolism.&#xD;
&#xD;
          3. Positive D-dimer.&#xD;
&#xD;
          4. Onset of PE symptoms occurring within the last seven days.&#xD;
&#xD;
          5. Aged 18 years or older.&#xD;
&#xD;
          6. Women of childbearing potential must have a negative serum pregnancy test (β-hCG)&#xD;
             result at the time of enrollment into the study. Both male and female participants&#xD;
             must agree to use effective contraception for the first 30 days after administration&#xD;
             of 99mTc ThromboView®.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The subject is unwilling or unable to provide written informed consent.&#xD;
&#xD;
          2. Allergy or other contraindication to intravenous iodinated contrast media.&#xD;
&#xD;
          3. Prior exposure to murine, chimeric or humanized antibodies.&#xD;
&#xD;
          4. Illicit intravenous drug use in the past 12 months.&#xD;
&#xD;
          5. Administration of therapeutic radioiodine in the past 6 months.&#xD;
&#xD;
          6. Life expectancy less than 90 days.&#xD;
&#xD;
          7. Previous participation in the current study.&#xD;
&#xD;
          8. Current enrollment in a clinical trial involving any other investigational agent.&#xD;
&#xD;
          9. Subject is unsuitable for SPECT scanning at the study Investigator's discretion (e.g.&#xD;
             residual detectable radioactivity within the lungs due to prior imaging studies or&#xD;
             treatment, preceding planned administration of 99mTc ThromboView®).&#xD;
&#xD;
         10. Inability to perform CTPA or 99mTc ThromboView imaging, for any reason.&#xD;
&#xD;
         11. Renal dysfunction: calculated creatinine clearance &lt; 30 mL/min.&#xD;
&#xD;
         12. Hepatic dysfunction: serum transaminases ≥ 3 x upper limit of normal range.&#xD;
&#xD;
         13. Hepatic dysfunction: subject has history of chronic or currently active liver disease.&#xD;
&#xD;
         14. Current pregnancy or lactation or conception intended within three months of&#xD;
             enrollment.&#xD;
&#xD;
         15. Subject is unsuitable for the study at the study Investigator's discretion. -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Morris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-3872</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Forde Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine at St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster University Medical Center</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>LBN4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <study_first_submitted>August 20, 2007</study_first_submitted>
  <study_first_submitted_qc>August 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2007</study_first_posted>
  <last_update_submitted>April 12, 2009</last_update_submitted>
  <last_update_submitted_qc>April 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2009</last_update_posted>
  <keyword>Pulmonary Embolism</keyword>
  <keyword>PE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>July 9, 2009</submitted>
    <returned>August 24, 2009</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

